Shows
IJGC conversationsMolecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2) with Angeles Alvarez SecordIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr Angeles Alvarez Secord to discuss Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2).
Angeles Alvarez Secord, MD, MHSc, is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Heath System. She received her undergraduate degree with honors from Carroll College in Helena, Montana and graduated AOA with honors from the University of Washington School of Medicine in Seattle, Washington. Dr. Secord completed her residency in obstetrics and gynecology and her fellowship in gynecologic oncology at the...2025-05-0535 minIJGC conversationsIJGC conversations 2025 April Editor's ChoiceIn this episode of the IJGC conversations 2025 April Editor's Choice, Editorial Fellow Stephanie Gill and Elise Mann Yates discusses the contents of the 2025 April issue of IJGC.
2025-04-3010 minIJGC conversationsReal-word PARPi Maintenance and Recurrence Patterns with Anna Fagotti and Matteo LoverroIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Matteo Loverro and Anna Fagotti to discuss Real-word PARPi Maintenance and Recurrence Patterns.
Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Oncology, Advanced Ovarian Cancer, Gynecological Cancer, and Laparoscopic Surgery.
Matteo Loverro is an ESGO fellow at Fondazione Policlinico Universitario A. Gemelli, IRCCS @unicatt.
2025-04-2941 minIJGC conversationsSubstantial LVSI and Recurrence in Endometrial Cancer with Nadeem Abu-Rustum and Christian DagherIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Nadeem Abu-Rustum and Christian Dagher to discuss Substantial LVSI and Recurrence in Endometrial Cancer.
Dr. Abu-Rustum is a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center. He is also a professor of obstetrics and gynecology at Weill Cornell Medical College. Dr. Abu-Rustum has a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system, and his clinical research focuses on surgical therapy...2025-04-1428 minIJGC conversationsSurgery for Stage IV Ovarian Cancer with Floriane JochumIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Surgery for Stage IV Ovarian Cancer.
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She recently completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials.
2025-04-0131 minIJGC conversationsRare gynecologic cancers with IJGC fellowsIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by the IJGC editorial fellows to discuss the IJGC Special Issue on Rare gynecologic cancers.
2025-03-2433 minIJGC conversationsQoL Assessment on SHAPE Trial with Sarah E. FergusonIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Sarah E. Ferguson to discuss QoL Assessment on SHAPE Trial.
Dr. Sarah Ferguson is a Gynecologic Oncologist at Princess Margaret Cancer Centre (University Health Network), a Professor and Vice Chair of Research in the Department of Obstetrics and Gynecology at the University of Toronto, and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Ferguson is currently the Head of Research for the Department of Obstetrics and Gynecology for Mount Sinai Hospital/University Health Network. Her clinical and research...2025-03-1734 minIJGC conversationsDe-escalation in Gynecologic Oncology with Núria AgustíIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí to discuss De-escalation in Gynecologic Oncology. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program
2025-03-1236 minIJGC conversationsIJGC conversations 2025 February Editor's ChoiceIn this episode of the IJGC conversations 2025 February Editor's Choice, Editorial Fellow Matteo Marchetti and Thomas Bartl discusses the contents of the 2025 February issue of IJGC.
2025-03-0210 minIJGC conversationsLANCE Trial: Results of Feasibility Phase with Jose Alejandro Rauh-HainIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jose Alejandro Rauh-Hain to discuss LANCE Trial: Results of Feasibility Phase.
Dr. Rauh-Hain is a Gynecologic Oncologist at the University of Texas MD Anderson Cancer Center. Born in Mexico City, he earned his medical degree from Universidad Panamericana and completed a research fellowship at Massachusetts General Hospital, focusing on preeclampsia biomarkers. He trained in Obstetrics and Gynecology at Massachusetts General and Brigham and Women's Hospital, followed by a Gynecologic Oncology fellowship at Harvard Medical School. He also holds an MPH from Harvard...2025-02-2536 minIJGC conversationsOvarian cancer risk among older patients with stable adnexal masses with Elizabeth (Betty) Suh-BurgmannIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Elizabeth (Betty) Suh-Burgmann to discuss Ovarian cancer risk among older patients with stable adnexal masses.
Dr. Elizabeth (Betty) Suh-Burgmann, originally from Boulder, Colorado, earned her Bachelor of Arts from Cornell University and completed her medical degree and residency at the University of California, San Francisco. Following a fellowship at Massachusetts General Hospital/Harvard Medical School, she joined Kaiser Permanente in 2000. She is the Chair of Gynecologic Oncology for Kaiser Permanente Northern California, which provides care to approximately 4.4 million patients. She is the...2025-02-1737 minIJGC conversationsPreoperative Tumor Size and Final Pathology in Cervical Cancer with Teresa PanIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Teresa Pan to discuss Preoperative Tumor Size and Final Pathology in Cervical Cancer. Dr. Teresa Pan is a gynonc doctor in the Innsbruck Medical University, Department of Gynecology and Obstetrics and has an interest in research in cervical cancer.
2025-02-1029 minIJGC conversationsOral Contraceptive Impact on p53 Signatures with Ramlogan SowamberIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Ramlogan Sowamber to discuss Oral Contraceptive Impact on p53 Signatures. Ramlogan Sowamber is a trainee at the University of British Columbia in the department of Medical Genetics, working with Dr. David Huntsman on understanding the impacts of opportunistic salpingectomy on ovarian cancer risk reduction from a genomic and molecular perspective. He is interested in understanding how genetics influences the mechanisms of cancer progression using genomic and functional approaches and how therapeutic interventions can be applied to various cancer subtypes.
2025-02-0343 minIJGC conversationsPRIMA Trial: Overall Survival Results with Antonio González-Martín
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG...2025-01-2742 minIJGC conversationsGOG3053/ENGOT EN11/KEYNOTE B21:dMMR Outcomes with Brian SlomovitzIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Brian Slomovitz to discuss the dMMR population Outcomes from the GOG3053/ENGOT EN11/KEYNOTE B21. Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies.
2025-01-2030 minIJGC conversationsRecent Trends in Radical Hysterectomy Approach after LACC Trial with Gabriel LevinIn this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gabriel Levin to discuss "Recent Trends in Radical Hysterectomy Approach after LACC Trial." Dr. Gabriel Levin is a gynecologic oncology Fellow at McGill University, and an assistant professor at the Hebrew University of Jerusalem. His research encompasses population database studies with clinical implication and innovations in medical education and health care.
2025-01-1332 minIJGC conversationsMIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie Plante
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss minimally invasive surgery in simple hysterectomy from the subanalysis of SHAPE trial.
Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important international trials the SHAPE trial and the Contessa trial.
2025-01-0628 minIJGC conversationsSecondary Cytoreductive Surgery in Endometrial Cancer with Francesco Fanfani
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Francesco Fanfani to discuss secondary cytoreductive surgery in endometrial cancer. Dr. Francesco Fanfani serves as an associate professor in gynecologic oncology at Fondazione Policlinico Universitario Agostino Gemelli, IRCCS in Rome, Italy.
2024-12-1933 min